A recent update to the tax and budget law is poised to change how Medicare negotiates drug prices — with major implications for people who depend on high-cost orphan drugs. Under the current system, Medicare negotiates prices for some expensive drugs that have few or...

The rapid expansion of GLP-1 drugs for weight loss and diabetes treatment may have implications far beyond the scale. According to a new Swiss Re analysis, if these medications are broadly adopted and used consistently, they could reduce all-cause mortality in the...

Small businesses that offer ACA-compliant health plans are facing some steep premium hikes in 2026. Preliminary filings from hundreds of insurers point to a median proposed increase of about 11 percent nationwide, with some state-level data suggesting an even higher...

https://youtube.com/shorts/Cz7BrmU1Guk?si=YYWkQwKV4gnsY39k

As we move into a future where longevity and health advances go hand in hand with evolving policy pressures, it’s worth pausing to look at two significant stories that are starting to intersect with everyday life: proposals to raise the full retirement age for Social...

There’s been a lot of discussion lately about the future of Social Security, and one of the biggest questions on the table is whether the full retirement age could be raised. Social Security Administration Commissioner Frank Bisignano, appointed under President Trump,...

Health care spending in employee benefit plans is being massively skewed: just 1% of plan participants are responsible for nearly 30% of total health care spending. Here’s what that means—and what employers and workers need to be aware of. Key Findings The top 1% of...

Health care costs are rising fast — and workers are headed for a tougher year ahead. Here's a breakdown of what’s happening, why it matters, and what to watch out for. The Current Picture Medical care inflation has surged to its highest point in three years. Prices...

Employer-sponsored health care costs in the U.S. are projected to jump significantly in 2026—exceeding $17,000 per employee—as medical inflation accelerates. Here are the factors driving this rise, and what companies are doing to manage the pressure. Key Takeaways...

The FDA has approved the first generic version of a GLP-1 receptor agonist specifically designed for weight loss. Teva Pharmaceuticals announced that the generic form of liraglutide (Saxenda) is now cleared for use, marking a significant step in expanding access to...